Court Rules that GE Healthcare Engaged in False Advertising Campaign Against Bracco Diagnostics Inc.
3/30/2009 9:24:17 AM
More...
|
Bracco Diagnostics Inc. and Lantheus Medical Imaging Enter into Agreement to Co-Promote Bracco’s CardioGen-82® (Rubidium Rb 82 Generator)
9/23/2008 3:24:32 PM
More...
|
Bracco Diagnostics Inc. Late-Breaking Clinical Trial Results Reveal No Statistically Significant Difference between Isovue(R)-370, or Visipaque(TM) 320 Injection in the Rate of CIN in High-Risk Patients Undergoing Computed Tomography
7/31/2008 6:44:18 AM
More...
|
Publicis Healthcare Rxecruiting Selected to Recruit for Bracco Diagnostics Inc.
6/9/2008 11:58:31 AM
More...
|
Bracco Diagnostics Inc. Finalizes Acquisition of E-Z-EM (EZM)
4/2/2008 9:45:20 AM
More...
|
E-Z-EM (EZM) Announces Completion of Merger
4/1/2008 10:50:18 AM
More...
|
E-Z-EM (EZM) to Merge with Bracco Diagnostics Inc. in $241 Million Cash Transaction
10/30/2007 8:49:20 AM
More...
|
Bracco Diagnostics Inc. (Jobs) and HealthTrust Purchasing Group Sign a Three-Year Agreement for Contrast Media
10/8/2007 12:08:08 AM
More...
|
Bracco International and ImaRx Therapeutics Enter into Strategic Licensing Agreement
7/3/2007 12:03:24 PM
More...
|
Bracco Diagnostics Inc. Release: The Latest Head-To-Head Clinical Study Comparing The Risk Of CIN between Two Contrast Agents Used In CE-MDCT Examinations Was Published In Investigative Radiology
11/1/2006 12:32:15 PM
More...
|
|